Table 3. Fatty acid content for sample groups determined by PI and TBARS
Fatty acid content (mg/100 g tissue) | HH | HL | LH | LL | SEM | p-value |
C10:0 | 28.33c | 29.08c | 33.92a | 30.85b | 0.98 | * |
C12:0 | 29.22c | 31.80b | 34.86a | 33.65a | 1.10 | * |
C14:0 | 154.06 | 169.91 | 162.98 | 167.31 | 11.57 | ns |
C16:0 | 2,156.83 | 2,208.81 | 2,222.41 | 2,202.15 | 20.29 | ns |
C16:1 | 330.25a | 323.46a | 331.62a | 307.52b | 9.86 | * |
C17:0 | 56.67 | 46.34 | 56.53 | 47.67 | 7.43 | ns |
C18:0 | 1,100.55 | 1,090.32 | 1,124.87 | 1,119.77 | 96.53 | ns |
C18:1 n-7 | 358.59 | 352.54 | 374.96 | 352.38 | 26.61 | ns |
C18:1 n-9 | 3,493.79b | 3,572.62a | 3,629.91a | 3,639.72a | 44.48 | * |
C18:2 n-3 | 42.50c | 55.42b | 64.06a | 65.43a | 3.52 | *** |
C18:3 n-6 | 751.70c | 846.82b | 976.96a | 979.57a | 35.40 | *** |
C20:0 | 31.87c | 34.53b | 39.57a | 37.39a | 1.62 | ** |
C20:1 | 79.69b | 89.04a | 90.44a | 90.67a | 5.55 | ** |
C20:2 | 43.38c | 49.97b | 55.58ab | 57.95a | 3.17 | *** |
C20:3 | 38.96b | 39.98b | 48.99a | 43.93b | 2.23 | * |
C20:4 | 158.49 | 152.64 | 175.23 | 172.92 | 17.35 | ns |
SFA | 3,556.65 | 3,611.69 | 3,674.19 | 3,636.92 | 56.91 | ns |
MUFA | 4,262.32b | 4,329.48a | 4,426.93a | 4,391.22a | 67.95 | * |
PUFA | 1,035.03b | 1,144.84b | 1,320.82a | 1,318.86a | 74.43 | *** |
n-6/n-3 | 17.69 | 15.28 | 15.25 | 14.97 | 2.03 | ns |
Total | 8,854.00b | 9,086.00b | 9,421.00a | 9,347.00a | 104.41 | * |
Different small letters within different sample groups were significantly different (p<0.05).
p<0.05;
p<0.01;
p<0.001.
PI, proteolytic index; TBARS, 2-thiobarbituric acid reactive substances; HH, PI and TBARS of high levels; HL, PI of high level and TBARS of low level; LH, PI of low level and TBARS of high level; LL, PI and TBARS of low levels; ns, no significance; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.